Cancer pain: From the development of mouse models to human clinical trials

Juan Miguel Jimenez Andrade, Patrick Mantyh

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations


Cancer-associated pain can be present at any time during the course of the disease, but the frequency and intensity of cancer pain tends to increase with advancing stages of cancer. In patients with advanced cancer, 62%–86% experience signicant pain, whichis described as moderate to severe in approximately 40%–50%and as very severe in 25%–30% (van den Beuken-van Everdingen et al. 2007). Bone cancer pain is the most common pain in patients with advanced cancer; two-thirds of patients with metastatic bone disease experience severe pain (Coleman 2006; Mercadante and Fulfaro 2007). Although bone is not a vital organ, many of the most common tumors (breast, prostate, thyroid, kidney, and lung) have a strong predilection for bone metastasis (Figure 4.1). Tumor metastases to the skeleton are major contributors to morbidity and mortality in metastatic cancer. Tumor growth in bone results in pain, hypercalcemia, anemia, increased susceptibility to infection, skeletal fractures.

Original languageEnglish (US)
Title of host publicationTranslational Pain Research
Subtitle of host publicationFrom Mouse to Man
PublisherCRC Press
Number of pages22
ISBN (Electronic)9781439812105
ISBN (Print)9781138116047
StatePublished - Jan 1 2009

ASJC Scopus subject areas

  • General Health Professions
  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology
  • General Neuroscience


Dive into the research topics of 'Cancer pain: From the development of mouse models to human clinical trials'. Together they form a unique fingerprint.

Cite this